Free access

Whole exome sequencing identifies causative compound heterozygous variants in PRF1 in late-onset familial hemophagocytic lymphohistiocytosis

Publication: LymphoSign Journal
28 November 2022

Abstract

Background: Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening disease in which cells of the immune system are overactivated, leading to uncontrolled inflammation and tissue destruction. Inherited or familial forms of HLH (FHL) are further classified into FHL1 to 5, based on the underlying genetic etiology. The most common form, FHL2, is associated with mutations in the PRF1 gene encoding perforin, a pore-forming glycoprotein required for natural killer and cytotoxic T cell-mediated apoptosis. Importantly, diagnosis of FHL can be challenging, particularly in late-onset cases in which presentation is delayed beyond the first years of life.
Aim: We report the essential role of whole exome sequencing in the diagnostic work-up of a patient with complex, late-onset FHL.
Methods: A comprehensive retrospective chart review was performed.
Results: Our patient presented at 11 years of age with recurrent fever, hepatosplenomegaly, and pancytopenia. In the following years, she was admitted to hospital on multiple occasions, including twice for febrile neutropenia, and once for febrile cytopenia. Serial immune evaluation revealed features of immune dysregulation. While HLH was suspected, she did not fulfil the diagnostic criteria. Initial genetic work-up involving a targeted primary immunodeficiency gene panel identified only a single novel variant of uncertain significance, c.T374C (p.I125T) in PRF1. Subsequently, research-based whole exome sequencing was performed which revealed a second variant, c.C272T (p.A91V), in the same gene. The expanded genetic findings, a set of compound heterozygous missense mutations in PRF1, strengthened the diagnosis of FHL. She later fulfilled the diagnostic criteria for HLH.
Conclusion: Whole exome sequencing identified compound heterozygous mutations in the PRF1 gene in a patient with late-onset FHL.
Statement of Novelty: We report the use of whole exome sequencing to identify compound heterozygous mutations in PRF1, including a novel p.I125T variant not previously identified in FHL.

Formats available

You can view the full content in the following formats:

REFERENCES

Abbas, A.L. 2018. Cellular and Molecular Immunology Ninth Edition. Elsevier.
Clementi R, Emmi L., Maccario R., Liotta F., Moretta L., Danesino C., and Aricó M. 2002. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood, Sept 100(6): 2266–2267.
Feldmann J., Le Deist F., Ouachée-Chardin M., Certain S., Alexander S., Quartier P., Haddad E., Wulffraat N., Casanova J.L., Blanche S., Fischer A., and de Saint Basile G. 2002. Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphocytosis. Br J Haematol. 117(4): 965–972.
Henter J.I., Horne A.C., Sabel M., Bryceson Y.T., and Henter J-I. 1991. Incidence and clinical presentation of primary hemophagocytic lymphohistiocytosis in Sweden. Acta Paediatr Scand. 62(2): 346–352.
Henter J.I., Horne A., Aricó M., Egeler R.M., Filipovich A.H., Imashuku S., Ladisch S., McClain K., Webb D., Winiarski J., and Janka G. 2007. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer, 48(2): 124–131.
Janka G. 2012. Familial and Acquired Hemophagocytic Lymphohistiocytosis. Annual Review of Medicine, 166(2): 95–109.
Lee M., Villanueva J., Sumegi J., Zhang K., Kogawa K., Davis J., and Filipovich A.H. 2004. Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphocytosis. J. Med. Genet. 41(2): 137–144.
Stepp S.E., Dufourcq-Lagelouse R., Deist F.L., Bhawan S., Certain S., Mathew P.A., Henter J.I., Bennett M., Fischer A., de Saint Basile G., and Kumar V. 1999. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science, 286: 1957–1959.
Terrell, C., and Jordan, M. 2013. Mixed hematopoietic or T-cell chimerism above a minimal threshold restores perforin-dependent immune regulation in perforin-deficient mice. Blood, 2618–2621.
Ueda I., Kurokawa Y., Koike K., Ito S., Sakata A., Matsumora T., Fukushima T., Morimoto A., Ishii E., and Imashuku S. 2007. Late-onset cases of familial hemophagocytic lymphohistiocytosis with missense perforin gene mutations. Am J Hematol, 82(6): 427–442.
Wang Y., Wang Z., Zhang J., Wei Q., Tang R., Qi J., Li L., Ye L., Wang J., and Ye L. 2014. Genetic Features of Late Onset Primary Hemophagocytic in Adolescence or Adulthood. PLoS ONE, 9(9): e107386.
Willenbring R.C., Ikeda Y., Pease L.R., and Johnson A.J. 2018. Human perforin gene variation is geographically distributed. Mol Genet Genomic Med, 6(1): 44–55.
Xin-Yi Liu Y.-B., Nie Y-B., Chen X-J., Gao X-H., Zhai L-J., and Min F-L. 2021. Adult onset type 2 familial hemophagocytic lymphohistiocytosis with PRF1 c.65delC/c.163C>T compound heterozygous mutations: A case report. World J Clin Cases, 9(10): 2289–2295.
Zhu G.H., Zhang L-P., Li Z-G., Wei A., Yang Y., Tian Y., Ma H-H., Wang D., Zhao X-X., Zhao Y-Z., Li N., Liu W., Wang T-Y., and Zhang R. 2020. Associations between PRF1 Ala91Val polymorphism and risk of hemophagocytic lymphohistiocytosis: a meta-analysis based on 1366 subjects. World J Pediatr. 16(6): 598–606.

Information & Authors

Information

Published In

cover image LymphoSign Journal
LymphoSign Journal
Volume 9Number 4December 2022
Pages: 85 - 91

History

Received: 16 November 2022
Accepted: 26 November 2022
Accepted manuscript online: 28 November 2022

Authors

Affiliations

Marina Sham [email protected]
Division of Clinical Immunology and Allergy, Department of Paediatrics, The Hospital for Sick Children and the University of Toronto, Toronto, ON
Rongbo Zhu
Division of Clinical Immunology and Allergy, Department of Medicine, Schulich School of Medicine and Dentistry, London, ON
Yehonatan Pasternak
Division of Clinical Immunology and Allergy, Department of Paediatrics, The Hospital for Sick Children and the University of Toronto, Toronto, ON
Allergy and Immunology Unit, Schneider Children’s Medical Center of Israel, Kipper Institute of Immunology, Petah Tikva

Metrics & Citations

Metrics

Other Metrics

Citations

Cite As

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

Cited by

1. Identification of novel compound heterozygous LRBA mutations associated with recurrent hemophagocytic lymphohistiocytosis and CNS manifestations

View Options

View options

PDF

View PDF

Full Text

View Full Text

Get Access

Media

Media

Other

Tables

Share Options

Share

Share the article link

Share on social media